Skip to main content
ISAC

Journal Integrated Track

Special Issue of Cytometry Part A:

We are pleased to invite submissions to a special issue of Cytometry Part A dedicated to research that will be presented at the upcoming CYTO 2027, the 40th Annual Congress of the International Society for the Advancement of Cytometry (ISAC), which will be held in Helsinki, Finland, June 5–9, 2027.

Authors who submit their research papers to this special issue will receive priority consideration for oral presentations at CYTO 2027, ahead of regular abstracts submitted through the conference website.

Importantly, acceptance of a paper (final acceptance, or acceptance with minor revisions) will be equivalent to acceptance for an oral presentation, allowing authors to secure their presenter slots early.

IMPORTANT DEADLINES:

  • Submission site opens: October 19, 2026
  • Submission Deadline: December 13, 2026

Scope and Areas of Interest

We welcome submissions that reflect the full breadth of cell analysis, including single-cell and spatio-temporal technologies, as well as their applications. We particularly encourage innovative work that pushes technological boundaries, develops new analytical approaches, or demonstrates impactful applications.

Submissions may include, but are not limited to:

Technologies & Instrumentation

  • Imaging technologies, tissue cytometry and high-content analysis - in vivo and live-cell imaging, functional and metabolic imaging, imaging flow cytometry, automated image acquisition systems, and related instrument innovations
  • Advanced flow cytometry - spectral flow cytometry, high-parameter analysis, novel fluorophores and reagents, and related instrument innovations
  • Mass cytometry and emerging modalities - metal-tagged reagents, and novel detection platforms and their applications
  • Multiplex imaging and spatial biology - multiplexed immunofluorescence for targeted spatial proteomics and transcriptomics, untargeted spatial transcriptomics, metabolomics, proteomics integration, and 3D tissue analysis
  • Label-free and mechanocytometry - biomechanical analysis of cells, endogenous fluorescence and higher harmonics analysis, quantitative phase imaging, impedance cytometry, Raman and Brillouin scattering spectroscopy, morphology-based classification
  • Nanotechnology – development and standardization of probes and devices, and applications to submicron structure analysis, including EVs
  • Microfluidics and cytometry engineering — miniaturized platforms, high-throughput sorting, portable devices, organ-on-chip integration, and novel fluidic designs

Computational Methods & Data Integration

  • Artificial intelligence and machine learning – machine learning for cell segmentation, classification, automated gating, predictive modeling, and AI-driven discovery
  • Spatial multi-omics integration and systems biology – spatial transcriptomics, proteomics, metabolomics, cell-cell interaction analysis and modeling, tissue microenvironment analysis, and multi-scale systems approaches
  • Computational cytometry and bioinformatics – dimensionality reduction, clustering algorithms, trajectory inference, data visualization, and software tool development
  • Single-cell multi-omics analysis and integration – combined genomics, transcriptomics, proteomics, epigenomics, and metabolomics with imaging and cytometry platforms
  • Data standards and reproducibility – FAIR data principles, standardization efforts, calibration methods, quality control frameworks, and data sharing platforms

Applications & translation

  • Immunology and immune profiling – immune cell characterization, immune repertoire analysis, vaccine response monitoring, and immunophenotyping
  • Clinical cytometry and diagnostics – disease biomarker discovery, minimal residual disease detection, patient stratification, and clinical decision support
  • Cell and gene therapy – CAR-T cell monitoring, therapeutic cell characterization, quality control for cell products, and therapy response assessment
  • Cancer biology and oncology – tumor microenvironment analysis, circulating tumor cells, cancer immunology, and precision oncology applications
  • Stem cell biology and developmental studies – stem cell characterization, differentiation tracking, organoid analysis, and developmental trajectories
  • Infectious disease and microbiology – pathogen detection, host-pathogen interactions, antimicrobial resistance, and vaccine development
  • Drug discovery and toxicology – compound screening, mechanism of action studies, off-target effect analysis, and safety assessment
  • Education and training – pedagogical approaches, educational resources, training program development, and best practices for teaching cytometry

Innovative technologies and transformative methodologies will receive the highest priority for both publication and oral presentation selection.

Multiple manuscript types accepted by Cytometry Part A are eligible for inclusion in this special issue, including:

  • Full research articles
  • Technical notes
  • Brief communications
  • OMIP (Optimized Multicolor Immunofluorescence Panel) manuscripts

We encourage authors to choose the format that best suits the scope and maturity of their research, ensuring that innovative ideas at every stage of development can be shared with the CYTO community.

Returning to a Valued Tradition

By submitting through this special issue, authors are participating in a process that revives a successful pathway from earlier CYTO conferences, where publication-oriented submissions were directly linked to oral presentation opportunities.

This approach not only strengthens the scientific rigor of the meeting but also accelerates visibility for the most impactful work in cytometry.

Editorial team

This special issue will be edited by:
  • Dr. Sara De Biasi, Conference Co-Chair, CYTO 2027
  • Dr. Raluca Niesner, Conference Chair, CYTO 2027
  • Dr. Bartek Rajwa, Editor-in-Chief, Cytometry Part A

Their combined leadership ensures the highest scientific standards and a seamless connection between the journal and the CYTO 2027 program.

Special Invitation to Students

We especially welcome contributions from students, particularly graduate students serving as lead authors.

This is an excellent opportunity for emerging researchers to share their work with the international cytometry community and gain visibility through both publication and oral presentation at CYTO 2027.

All student-led submissions to this special issue will automatically be considered for the ISAC Exceptional Student Award, which recognizes outstanding research contributions by emerging cytometrists. This offers graduate students a unique opportunity to gain both publication visibility and recognition at the international level.

Am I Eligible?

If you’re a graduate student, whether pursuing a Master’s degree or PhD, conducting cytometry research, you’re eligible to submit.

The key requirement is that you serve as the first or lead author on the manuscript and plan to present the work yourself at CYTO 2027.

We also welcome undergraduate students who are conducting substantial research and can take the lead on their manuscript.

This opportunity is designed for emerging researchers who want to step into the spotlight and share their innovative work with the international cytometry community.

What About My Advisor?

Your advisor plays an important supporting role in this process. They should be listed as a co-author on the manuscript, typically as the senior or corresponding author, but you must be listed as first author to qualify for the special benefits this track offers.

Being the first author is what makes your submission student-led, which unlocks:

  • Automatic consideration for the ISAC Exceptional Student Award
  • Priority student recognition at the conference

Submission Timing

Submissions are open immediately through the Cytometry Part A submission portal.

  • Showcase your most innovative findings
  • Secure an oral presentation slot early
  • Contribute to a landmark issue celebrating “Cells Under Midnight Sun”

We look forward to your contributions and to celebrating the next wave of cytometric innovation at CYTO 2027 in Helsinki, Finland!

Submission Process and Technical Instructions

IMPORTANT DEADLINES:

  • Submission site opens: October 19, 2026
  • Submission Deadline: December 13, 2026

To ensure manuscripts are properly linked to the CYTO 2027 program, all interested authors must complete two submission steps.

Please follow these instructions carefully.

Step 1: Submit to Cytometry Part A

All manuscripts intended for inclusion in the Cytometry Part A Special Issue must first be submitted directly through the journal’s online submission system:

Submit to Cytometry Part A

Upon completing your submission, you will receive an official Submission ID number, which will serve as the primary link between your journal submission and your CYTO 2027 abstract.

Once you have received your Cytometry Part A Submission ID number, continue to Step 2.

Step 2: Submit to the CYTO 2027 Abstract Portal

  • Submit an Oral Abstract to CYTO 2027.
  • When prompted, indicate that your submission is part of the Cytometry Part A Journal – Integrated Track and carefully read the prompt.
  • Include your Submission ID number at the end of your abstract in the description box.

Submit an Oral Abstract

Following these steps is critical to ensuring your submissions are properly identified for seamless coordination between the Cytometry Part A editorial process and the CYTO 2027 program review.

Understanding the Review and Presentation Process

To ensure transparency and help authors make informed decisions, the manuscript review outcomes and their implications for CYTO 2027 presentation eligibility are described below.

If Your Paper Receives Minor Revisions

You are guaranteed an oral presentation slot at CYTO 2027.

  • Complete the minor revisions by the editorial deadline.
  • Your abstract will be automatically moved to the oral presentation track.
  • You will receive confirmation of your speaking slot in February 2027.
  • Your presentation slot is secured even while you complete the revisions.

If Your Paper Requires Major Revisions

You remain eligible for an oral presentation, subject to successful revision.

  • Complete major revisions by January 24, 2027.
  • If your revised manuscript is accepted by this deadline, you will receive an oral presentation slot.
  • If the revision process extends beyond this deadline, your abstract will enter the standard CYTO 2027 review process, where it will be evaluated competitively alongside regular abstract submissions.
  • The quality of both your revised manuscript and your abstract will be considered in oral presentation decisions.

If Your Paper Is Rejected

Your abstract automatically remains active in the conference system.

There is no penalty for manuscript rejection. Your conference participation proceeds through these options:

  • Your abstract will be reviewed through the standard CYTO 2027 abstract evaluation process.
  • You will be considered for:
    • Regular oral presentation through competitive review
    • Poster presentation
  • Your conference submission is evaluated independently based on its scientific merit and relevance to the CYTO community.
  • You are encouraged to address reviewer comments from the manuscript review in your conference presentation.
  • You may revise and resubmit your manuscript to Cytometry Part A through the regular submission process at any time.

Why Submit Both a Manuscript and an Abstract?

We recognize this two-step process may seem redundant, but both submissions serve essential and distinct purposes.

Your Manuscript Submission:

  • Undergoes rigorous peer review for publication
  • Determines your eligibility for priority oral presentation
  • Contributes to a permanent, citable scientific record
Your Abstract Submission:
  • Provides a backup option if your manuscript requires extensive revisions or is not accepted
  • Enables the program committee to plan session themes, timing, and thematic groupings
  • Ensures your work appears in the official CYTO 2027 conference proceedings
  • Helps attendees preview talks and plan their conference schedule
  • Guarantees you maintain a presence at the conference regardless of manuscript status

Can I Submit Based on a Preprint?

Yes!

We welcome and encourage submissions based on preprints posted on servers such as bioRxiv, medRxiv, or arXiv.

If you’ve already shared your work as a preprint, you can submit it directly to this special issue. In fact, a preprint may speed up your submission timeline since much of the writing is already complete.